About Julian Baker
Julian Baker is a director and 10% owner at Kodiak Sciences.
Form D filings name Julian Baker as a director at Alumis.
Julian Baker reports to the SEC as a director or major shareholder of 52 public companies, including BeOne Medicines (ONC), Replimune Group (REPL) and Celcuity (CELC).
Julian Baker first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Julian Baker in the role, so the role may have started earlier or lasted longer.
KI
Kodiak Sciences Inc.
Director and 10% owner
2018 – 2026 · Public company (KOD)
BL
BeOne Medicines Ltd.
Director and 10% owner
2016 – 2026 · Public company (ONC)
RI
Replimune Group, Inc.
Director and 10% owner
2025 – 2026 · Public company (REPL)
CI
Celcuity Inc.
10% owner
2025 – 2026 · Public company (CELC)
IC
Incyte Corp.
Director and 10% owner
2006 – 2026 · Public company (INCY)
VI
vTv Therapeutics Inc.
Director
2024 – 2026 · Public company (VTVT)
KI
Kymera Therapeutics, Inc.
Director and 10% owner
2024 – 2026 · Public company (KYMR)
MI
Madrigal Pharmaceuticals, Inc.
Director
2023 – 2026 · Public company (MDGL)
PI
Prelude Therapeutics Inc
Director and 10% owner
2020 – 2026 · Public company (PRLD)
DI
Denali Therapeutics Inc.
Director
2025 – 2026 · Public company (DNLI)
KP
Kiniksa Pharmaceuticals International, plc
Director and 10% owner
2018 – 2026 · Public company (KNSA)
AI
Acadia Pharmaceuticals Inc.
Director and 10% owner
2012 – 2026 · Public company (ACAD)
TI
TScan Therapeutics, Inc.
Director and 10% owner
2021 – 2026 · Public company (TCRX)
DA
DBV Technologies S.A.
Director and 10% owner
2021 – 2026 · Public company (DBVT)
BP
Bicycle Therapeutics PLC
Director and 10% owner
2024 – 2026 · Public company (BCYC)
EI
Entrada Therapeutics, Inc.
10% owner
2021 – 2025 · Public company (TRDA)
KI
Kala Bio, Inc.
10% owner
2024 – 2025 · Public company (KALA)
II
IGM Biosciences, Inc.
Director and 10% owner
2019 – 2025 · Public company (IGMS)
IP
Immunocore Holdings plc
Director
2024 – 2025 · Public company (IMCR)
SI
Sera Prognostics, Inc.
10% owner
2025 · Public company (SERA)
NI
Neurogene Inc.
Director and 10% owner
2015 – 2023 · Public company (NGNE)
SI
Seagen Inc.
Director and 10% owner
2006 – 2023 · Public company (SGEN)
BI
Bellicum Pharmaceuticals, Inc.
10% owner
2015 – 2023 · Public company (BLCM)
AI
Atreca, Inc.
10% owner
2019 – 2023 · Public company (BCEL)
TC
Talis Biomedical Corp
Director and 10% owner
2021 – 2023 · Public company (TLIS)
SI
Spyre Therapeutics, Inc.
Director
2021 · Public company (SYRE)
AI
Alexion Pharmaceuticals, Inc.
Director
2015 – 2020 · Public company (ALXN)
ZI
Zymeworks BC Inc.
Director
2020 · Public company (ZYME)
GI
Genomic Health Inc.
Director and 10% owner
2006 – 2019 · Public company (GHDX)
AI
Aceragen, Inc.
Director and 10% owner
2006 – 2019 · Public company (ACGN)
HI
HOOKIPA Pharma Inc.
10% owner
2019 · Public company (HOOK)
PI
Principia Biopharma Inc.
10% owner
2018 · Public company (PRNB)
IC
Invitae Corp
10% owner
2015 – 2018 · Public company (NVTA)
MI
Mirati Therapeutics, Inc.
10% owner
2013 – 2017 · Public company (MRTX)
RI
Rhythm Pharmaceuticals, Inc.
10% owner
2017 · Public company (RYTM)
BI
Biocryst Pharmaceuticals Inc.
10% owner
2007 – 2016 · Public company (BCRX)
II
Intellia Therapeutics, Inc.
10% owner
2016 · Public company (NTLA)
XC
XOMA Royalty Corp
Director and 10% owner
2012 – 2015 · Public company (XOMA)
SC
Synageva Biopharma Corp.
Director and 10% owner
2006 – 2015 · Public company (GEVA)
AI
Ardea Biosciences, Inc.
Director and 10% owner
2006 – 2012 · Public company (RDEA)
OI
Ocera Therapeutics, Inc.
10% owner
2012 · Public company (OCRX)
PI
Pharmacyclics Inc.
10% owner
2011 – 2012 · Public company (PCYC)
DI
Diadexus, Inc.
10% owner
2010 – 2012 · Public company (DDXS)
AC
Adolor Corp.
10% owner
2010 – 2012 · Public company (ADLR)
VI
Viropharma Inc.
10% owner
2006 – 2011 · Public company (VPHM)
AI
Auxilium Pharmaceuticals Inc.
10% owner
2010 – 2011 · Public company (AUXL)
HI
Heron Therapeutics, Inc.
10% owner
2009 – 2011 · Public company (HRTX)
NC
Neurogen Corp.
Director and 10% owner
2006 – 2009 · Public company (NRGN)
AI
Allos Therapeutics Inc.
10% owner
2006 – 2009 · Public company (ALTH)
TI
Tapestry Pharmaceuticals, Inc.
10% owner
2006 – 2008 · Public company (TPPH)
SI
Synvista Therapeutics, Inc.
10% owner
2007 · Public company (SYI)
II
Innoviva, Inc.
Director
2006 · Public company (INVA)
Key Colleagues at Startups
The people Julian Baker works with at each company, as listed on that company's latest Form D.
Alumis Inc. · Form D, Mar 11, 2024
RG
Richard Gaster
Director
ZY
Zhengbin Yao
Director
SS
Sapna Srivastava
Director
MB
Martin Babler
CEO and director
AC
Alan Colowick
Director
JT
James Tananbaum
Director
SA
Srinivas Akkaraju
Director